Food and Drug Amendments of 2022
Sponsor: ANNA ESHOO (D-CA)
Food and Drug Amendments of 2022 This bill reauthorizes Food and Drug Administration (FDA) user fee programs for certain drugs and devices, establishes requirements to increase diversity in clinical trials, and modifies requirements relating to the overall supply chain for drugs and devices. Specifically, the bill reauthorizes through FY2027 the FDA user fee programs for prescription drugs, medical devices, generic drugs, and biosimilars. The bill also requires the development of action plans and related reporting to increase the diversity of participants in clinical trials.
Health Topic assigned by the Congressional Research Service.
Who won, and how much of the country was behind them
The dotted gap is 4.8% of U.S. adults whose member did not vote, voted “present,” or whose seat was vacant.
| Side | Outcome | Votes | Share of U.S. adults |
|---|---|---|---|
| Yea | Won | 386 | 88.8% |
| Nay | Lost | 27 | 6.4% |
| Not represented on this question | No position taken | 0 | 4.8% |